Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOPE trial: hydroxychloroquine as post-exposure prophylaxis for SARS-CoV-2
KCT0004907Phase 3Recruiting
- Sponsor
- Yonsei University Health System
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Yonsei University Health System. Started Apr 2020; status: recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on KCT0004907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004907.